Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer ; volume:21 ; number:1 ; day:4 ; month:9 ; year:2021 ; pages:1-8 ; date:12.2021
BMC gastroenterology ; 21, Heft 1 (4.9.2021), 1-8, 12.2021
- Creator
-
Kaprio, Tuomas
Lindström, Alexander M.
Rasila, Tiina
Saavalainen, Olga
Beilmann-Lehtonen, Ines
Mustonen, Harri
Haglund, Caj
Andersson, Leif C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-021-01918-y
- URN
-
urn:nbn:de:101:1-2021111720440036515253
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kaprio, Tuomas
- Lindström, Alexander M.
- Rasila, Tiina
- Saavalainen, Olga
- Beilmann-Lehtonen, Ines
- Mustonen, Harri
- Haglund, Caj
- Andersson, Leif C.
- SpringerLink (Online service)
Other Objects (12)
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
Elevated miR-301a expression indicates a poor prognosis for breast cancer patients
CDCA8 as an independent predictor for a poor prognosis in liver cancer
Small bowel angioectasia as a marker of frailty and poor prognosis
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
Elevated miR-301a expression indicates a poor prognosis for breast cancer patients
CDCA8 as an independent predictor for a poor prognosis in liver cancer
Small bowel angioectasia as a marker of frailty and poor prognosis
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
Elevated miR-301a expression indicates a poor prognosis for breast cancer patients
CDCA8 as an independent predictor for a poor prognosis in liver cancer
Small bowel angioectasia as a marker of frailty and poor prognosis